Site içinde arama yapın

Sonali Sonkusare bir ses eklendi Other
2026-03-23 07:15:12 -

Alzheimer's Disease Diagnostic Market: Industry Dynamics, Growth Analysis & Strategic Insights
"Executive Summary Alzheimer's Disease Diagnostic Market: Growth Trends and Share Breakdown Data Bridge Market Research analyses that the alzheimer's disease diagnostic market was valued at USD 10,376.30 million in 2022 and is expected to reach the value of USD 22,454.74 million by the year 2030, at a CAGR of 9.40% during the forecast period. In this competitive marketplace, businesses are...

0 Yorumlar 0 hisse senetleri 177 Views 0 önizleme

Please log in to like, share and comment!
Anuj Mrfr bir ses eklendi Health
2026-04-04 17:21:35 -

Alzheimer's Disease Diagnostic Market: How Is the Alzheimer's Diagnostic Market Being Transformed by New Treatments?
FDA-approved amyloid-targeting therapies — lecanemab (Leqembi) and donanemab (Kisunla) receiving FDA approval for early AD treatment — have fundamentally transformed Alzheimer's diagnostics from a primarily academic exercise toward a clinically necessary component of treatment pathway qualification, with the Alzheimer's Disease Diagnostic Market reflecting the treatment-driven...

0 Yorumlar 0 hisse senetleri 76 Views 0 önizleme

Please log in to like, share and comment!
Divakar Kolhe bir ses eklendi Health
2025-09-19 07:28:48 -

Alzheimer’s Disease Diagnostic Market Key Manufacturers: Leading Players and Strategies
The Alzheimer’s Disease Diagnostic Market Key Manufacturers include Roche, GE Healthcare, Siemens Healthineers, Eli Lilly, and Biogen. These companies dominate due to strong R&D capabilities, broad distribution networks, and robust product portfolios. Imaging solutions, biomarker assays, and AI-assisted diagnostics remain core revenue drivers. Key manufacturers are focusing on...

0 Yorumlar 0 hisse senetleri 956 Views 0 önizleme

Please log in to like, share and comment!